December 23, 2015 | Letter

Excerpt: During the November 19, 2015 hearing before the Subcommittee on Oversight and Investigations, Dr Robin Robinson, the Director of the Biological Advanced Research Development Authority (BARDA) told the Subcommittee on Oversight and Investigations that BARDA is currently testing stockpiled pandemic influenza vaccines.

>>
December 18, 2015 | Letter

Excerpt: The volume of imported drugs, the growing numbers of foreign entities producing these drugs, and the increasing complexity of the pharmaceutical supply chain have all significantly complicated FDA’s ability to provide sufficient oversight

>>
December 17, 2015 | Letter

Excerpt: EPA's actions potentially undermined the integrity of the rulemaking process concerning WOTUS, and call into question the use of social media to promote other rulemaking activity. For example, EPA undertook an extensive social media messaging campaign in support of its Clean Power Plan, authoring blog posts, and posting messages on Facebook and Twitter.

>>
December 15, 2015 | Letter

Pursuant to Rules X and XI of the United States House of Representatives, the Committee on Energy and Commerce is examinig the implementation of the Patient Protection and Affordable Care Act (ACA).

>>
December 11, 2015 | Letter

We are writing to request that the Government Accountability Office (GAO) conduct a study to assess the Food and Drug Administration's (FDA) regulatory pathway for reviewing generic versions of nonbiologic complex drugs (NBCDs). 

>>
December 9, 2015 | Letter

Excerpt: We write to request information related to the Centers for Medicare and Medicaid Services’ (CMS) oversight of state exchanges, particularly those that have transitioned to the federally-facilitated marketplace (HealthCare.gov or FFM).

To read the letter, click here.

>>

Pages